Activity of various thiocarboxanilide derivatives against wild-type and several mutant human immunodeficiency virus type 1 strains
- 30 June 1995
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 27 (3) , 219-236
- https://doi.org/10.1016/0166-3542(95)00006-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- HIV resistance to reverse transcriptase inhibitorsBiochemical Pharmacology, 1994
- Knocking-Out Concentrations of HIV-1-Specific Inhibitors Completely Suppress HIV-1 Infection and Prevent the Emergence of Drug-Resistant VirusVirology, 1993
- Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replicationAntimicrobial Agents and Chemotherapy, 1993
- HIV‐1‐specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptaseMedicinal Research Reviews, 1993
- HIV-1-Specific Reverse Transcriptase Inhibitors Show Differential Activity against HIV-1 Mutant Strains Containing Different Amino Acid Substitutions in the Reverse TranscriptaseVirology, 1993
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989